Citations

Gregson, J., P. Kaleebu, V. C Marconi, C. van Vuuren, N. Ndembi, R. L Hamers, P. Kanki, C. J Hoffmann, S. Lockman, D. Pillay, T. de Oliveira, N. Clumeck, G. Hunt, B. Kerschberger, R. W Shafer, C. Yang, E. Raizes, R. Kantor, and R. K Gupta. "Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study." Lancet Infect Dis 17, no. 3 (2017): 296-304.

Phillips, A. N, V. Cambiano, F. Nakagawa, P. Revill, M. R Jordan, T. B Hallett, M. Doherty, A. De Luca, J. D Lundgren, M. Mhangara, T. Apollo, J. Mellors, B. Nichols, U. Parikh, D. Pillay, T. Rinke de Wit, K. Sigaloff, D. Havlir, D. R Kuritzkes, A. Pozniak, D. van de Vijver, M. Vitoria, M. A Wainberg, E. Raizes, S. Bertagnolio, and Working Group on Modelling Potential Responses to High Levels of Pre, A. R. T. Drug Resistance in Sub-Saharan Africa. "Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study." Lancet HIV 5, no. 3 (2018): e146-e154.